Clinical Trials Logo

Enuresis clinical trials

View clinical trials related to Enuresis.

Filter by:

NCT ID: NCT00998790 Completed - Clinical trials for Stress Urinary Incontinence

A Post-Market Study of the AMS AdVanceā„¢ Male Sling System for the Treatment of Male Stress Urinary Incontinence

Start date: January 2007
Phase: N/A
Study type: Interventional

A prospective, multi-center study of the AdVance Male Sling for Stress Urinary Incontinence. The purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication. This study is not designed to statistically demonstrate safety and efficacy of the device.

NCT ID: NCT00996489 Completed - Clinical trials for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

Start date: January 8, 2008
Phase: N/A
Study type: Interventional

This is a post approval study of Coaptite® in the treatment of female urinary incontinence.

NCT ID: NCT00942370 Completed - Clinical trials for Stress Urinary Incontinence

Electromyographic (EMG) and Mechanomyographic (MMG) Comparison

EMG-MMG
Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess the delay between the detection (by mechanomyography-MMG) of rectus abdominis contraction and the detection of cough in cough effort.

NCT ID: NCT00915525 Completed - Clinical trials for Urinary Incontinence

Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Start date: February 1, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.

NCT ID: NCT00904969 Completed - Clinical trials for Urinary Incontinence, Stress

A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence

AMS051
Start date: September 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication.

NCT ID: NCT00847535 Completed - Clinical trials for Stress Urinary Incontinence

An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

Start date: October 9, 2008
Phase: Phase 2
Study type: Interventional

This is a clinical investigation approved by US FDA and Canadian Health Authority to study the safety and potential effectiveness of the autologous muscle cells for the treatment of stress urinary incontinence.

NCT ID: NCT00691093 Completed - Clinical trials for Urinary Incontinence

Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy

Start date: July 2008
Phase:
Study type: Observational

This is a observational study in patients treated with fesoterodine (Toviaz), who have failed on previous treatment for overactive bladder. It will collect epidemiological data and investigate the efficacy and tolerability of fesoterodine.

NCT ID: NCT00688298 Completed - Clinical trials for Stress Urinary Incontinence

Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence

Start date: May 2004
Phase: N/A
Study type: Interventional

The pre-pubic approach of the tension free vaginal sling placement is a new approach in the treatment of SUI. The retropubic approach of the tension free vaginal sling is the standard method of device delivery; in addition a suprapubic and a transobturator approach are alternative methods of delivery. All of these delivery approach systems are intended to place the mesh "tension free" in the mid-urethra. There are currently no studies that investigate the pre-pubic delivery approach in the United States. However, the largest series of cases in Europe using the pre-pubic system was done by Ulmsten (published in the European Journal of Obstetrics and Gynecology and Reproductive Biology) 107 (2003) 205-207, titled " Pre-Pubic tension free vaginal tape application: an alternative to classic tension free vaginal tape application in selected patients with SUI." The primary objective of this study is to evaluate the feasibility of using a pre-pubic approach to the placement of a mid-urethral vaginal mesh. - Demonstrate the mesh can be properly placed in the mid-urethra using a pre-pubic approach; - Assess the performance of the delivery device by measuring the ease of use, technical complexity, and instrument difficulties

NCT ID: NCT00634608 Completed - Obesity Clinical Trials

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Start date: February 2008
Phase: N/A
Study type: Interventional

The specific aim of this proposed project is to implement a standard process for integrating MedlinePlus health information prescriptions into the clinic workflow. Hypothesis 1: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more likely to seek information / use MedlinePlus compared with individuals in the control group. Hypothesis 2: Individuals in the intervention group who receive tailored email health information with provider selected MedlinePlus links and added commentary for patient specific conditions will be more satisfied with the information received compared with individuals in the control group.

NCT ID: NCT00629083 Completed - Clinical trials for Stress Urinary Incontinence

Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

Start date: April 2008
Phase: N/A
Study type: Interventional

The primary purpose of this study is to demonstrate the safety and effectiveness of Bulkamid® in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) in adult women who have SUI or stress predominant mixed incontinence